Bio-equivalence
Bio-equivalence is defined as the observation and finding similarities of one or more drugs. Formulations involve the same active substance or element are called bio-equivalence. If their rate of absorption and formulations are identical, they are pronounced to be bioequivalence drugs. The United States food and Drug Administration (FDA) has explained bio-equivalence as "the absence of a significant difference in the rate and range to which the active ingredient or active subdivision in pharmaceutical equivalents or pharmaceutical substitute becomes available at the site of drug action when administered at the same molar dose below similar conditions in an appropriately designed study.
- Rate Of immersion
- Expression of Medicines
Related Conference of Bio-equivalence
6th International Conference on Clinical Pharmacology and Toxicology
Bio-equivalence Conference Speakers
Recommended Sessions
- Behavior toxicology
- Bio-availability
- Bio-equivalence
- Biochemical Pharmacology
- Biologic drugs
- Clinical and medical pharmacology
- Drug discovery and Drug development
- Drug Safety
- Environmental Toxicology
- Genotoxicity
- Microbial Toxicology
- Molecular Pharmacology
- Nanomedicine and Nanotechnology
- Pharmaceutical biotechnology
- Pharmacodynamics
- Pharmacogenomics
- Pharmacokinetics
- Pharmacology and Toxicology
- Pharmacovigilance
- Route of administration
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinicalpharmacology2025 (Canada)
- Air and Water quality - TOXICOLOGY CONGRESS 2025 (France)
- Air pollution and Health - TOXICOLOGY CONGRESS 2025 (France)
- Cardiovascular Pharmacology - clinicalpharmacology2025 (Canada)
- Chemical Safety and Regulation - TOXICOLOGY CONGRESS 2025 (France)
- Climate Change and Health Effects - TOXICOLOGY CONGRESS 2025 (France)
- Clinical Toxicology of Drugs of Abuse - clinicalpharmacology2025 (Canada)
- Clinical Trials and Regulatory Affairs - clinicalpharmacology2025 (Canada)
- Drug Interactions and Polypharmacy - clinicalpharmacology2025 (Canada)
- Ecotoxicology - TOXICOLOGY CONGRESS 2025 (France)
- Emerging Contaminants - TOXICOLOGY CONGRESS 2025 (France)
- Emerging Trends in Clinical Pharmacology - clinicalpharmacology2025 (Canada)
- Environmental and Occupational Toxicology - clinicalpharmacology2025 (Canada)
- Environmental Contaminants - TOXICOLOGY CONGRESS 2025 (France)
- Environmental Health - TOXICOLOGY CONGRESS 2025 (France)
- Environmental Justice - TOXICOLOGY CONGRESS 2025 (France)
- Food Safety and Toxicants - TOXICOLOGY CONGRESS 2025 (France)
- Future Directions in Clinical Pharmacology and Toxicology - clinicalpharmacology2025 (Canada)
- Hazardous Waste Management - TOXICOLOGY CONGRESS 2025 (France)
- Industrial Toxicology - TOXICOLOGY CONGRESS 2025 (France)
- Innovations in Drug Development and Therapeutics - clinicalpharmacology2025 (Canada)
- Nanotoxicology - TOXICOLOGY CONGRESS 2025 (France)
- Natural Products and Toxicology - clinicalpharmacology2025 (Canada)
- Neuropharmacology and Toxicology - clinicalpharmacology2025 (Canada)
- Neurotoxicology - TOXICOLOGY CONGRESS 2025 (France)
- Occupational Health and Safety - TOXICOLOGY CONGRESS 2025 (France)
- Pediatric and Geriatric Pharmacology - clinicalpharmacology2025 (Canada)
- Pesticide Toxicology - TOXICOLOGY CONGRESS 2025 (France)
- Pharmacogenomics and Personalized Medicine - clinicalpharmacology2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - TOXICOLOGY CONGRESS 2025 (France)
- Pharmacokinetics and Pharmacodynamics - clinicalpharmacology2025 (Canada)
- Public Health Impacts - TOXICOLOGY CONGRESS 2025 (France)
- Radio Biology - TOXICOLOGY CONGRESS 2025 (France)
- Risk Assessment and Management - TOXICOLOGY CONGRESS 2025 (France)
- Toxicity Mechanisms - TOXICOLOGY CONGRESS 2025 (France)
- Toxicokinetics and Toxicodynamics - TOXICOLOGY CONGRESS 2025 (France)
- Toxicology - TOXICOLOGY CONGRESS 2025 (France)
- Toxicology and Risk Assessment - clinicalpharmacology2025 (Canada)